Pedro E Perez-Cruz1, Omar Shamieh2, Carlos Eduardo Paiva3, Jung Hye Kwon4, Mary Ann Muckaden5, Eduardo Bruera6, David Hui7. 1. Department of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. 2. Department of Palliative Care, King Hussein Cancer Center, Amman, Jordan. 3. Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil. 4. Department of Medical Oncology, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea. 5. Department of Palliative Care, Tata Memorial Center, Mumbai, India. 6. Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 7. Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: dhui@mdanderson.org.
Abstract
CONTEXT: Attrition is common in longitudinal observational studies in palliative care. Few studies have examined predictors of attrition. OBJECTIVES: To identify patient characteristics at enrollment associated with attrition in palliative oncology outpatient setting. METHODS: In this longitudinal observational study, advanced cancer patients enrolled in an outpatient multicenter study were assessed at baseline and two to five weeks later. We compared baseline characteristics between patients who returned for follow-up and those who dropped out. RESULTS: Seven hundred forty-four patients were enrolled from Jordan, Brazil, Chile, Korea, and India. Attrition rate was 33%, with variation among countries (22%-39%; P = 0.023). In univariate analysis, baseline predictors for attrition were cognitive failure (odds ratio [OR] 1.23 per point in Memorial Delirium Assessment Scale; P < 0.01), functional status (OR 1.55 per 10-point decrease in Karnofsky Performance Status; P < 0.01), Edmonton Symptom Assessment Scale [ESAS] physical score (OR 1.03 per point; P < 0.01), ESAS emotional score (OR 1.05 per point; P < 0.01), and shorter duration between cancer diagnosis and palliative care referral in months (OR 0.89 per log; P = 0.028). In multivariate analysis, cognitive failure (OR 1.12 per point; P = 0.007), ESAS physical score (OR 1.18 per point; P = 0.027), functional status (OR 1.35 per 10-point decrease; P < 0.001), and shorter duration from cancer diagnosis (OR 0.86 per log; P = 0.01) remained independent predictors of attrition. CONCLUSION: Advanced cancer patients with cognitive failure, increased physical symptoms, poorer performance status, and shorter duration from cancer diagnosis were more likely to dropout. These results have implications for research design, patient selection, and data interpretation in longitudinal observational studies.
CONTEXT: Attrition is common in longitudinal observational studies in palliative care. Few studies have examined predictors of attrition. OBJECTIVES: To identify patient characteristics at enrollment associated with attrition in palliative oncology outpatient setting. METHODS: In this longitudinal observational study, advanced cancerpatients enrolled in an outpatient multicenter study were assessed at baseline and two to five weeks later. We compared baseline characteristics between patients who returned for follow-up and those who dropped out. RESULTS: Seven hundred forty-four patients were enrolled from Jordan, Brazil, Chile, Korea, and India. Attrition rate was 33%, with variation among countries (22%-39%; P = 0.023). In univariate analysis, baseline predictors for attrition were cognitive failure (odds ratio [OR] 1.23 per point in Memorial Delirium Assessment Scale; P < 0.01), functional status (OR 1.55 per 10-point decrease in Karnofsky Performance Status; P < 0.01), Edmonton Symptom Assessment Scale [ESAS] physical score (OR 1.03 per point; P < 0.01), ESAS emotional score (OR 1.05 per point; P < 0.01), and shorter duration between cancer diagnosis and palliative care referral in months (OR 0.89 per log; P = 0.028). In multivariate analysis, cognitive failure (OR 1.12 per point; P = 0.007), ESAS physical score (OR 1.18 per point; P = 0.027), functional status (OR 1.35 per 10-point decrease; P < 0.001), and shorter duration from cancer diagnosis (OR 0.86 per log; P = 0.01) remained independent predictors of attrition. CONCLUSION:Advanced cancerpatients with cognitive failure, increased physical symptoms, poorer performance status, and shorter duration from cancer diagnosis were more likely to dropout. These results have implications for research design, patient selection, and data interpretation in longitudinal observational studies.
Authors: Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart Journal: Psychooncology Date: 2011-07-12 Impact factor: 3.894
Authors: Emily K Chen; Catherine Riffin; M Cary Reid; Ronald Adelman; Marcus Warmington; Sonal S Mehta; Karl Pillemer Journal: J Palliat Med Date: 2014-06-02 Impact factor: 2.947
Authors: Andrea C Phelps; Paul K Maciejewski; Matthew Nilsson; Tracy A Balboni; Alexi A Wright; M Elizabeth Paulk; Elizabeth Trice; Deborah Schrag; John R Peteet; Susan D Block; Holly G Prigerson Journal: JAMA Date: 2009-03-18 Impact factor: 56.272
Authors: Michael Downing; Francis Lau; Mary Lesperance; Nicholas Karlson; Jack Shaw; Craig Kuziemsky; Steve Bernard; Laura Hanson; Lola Olajide; Barbara Head; Christine Ritchie; Joan Harrold; David Casarett Journal: J Palliat Care Date: 2007 Impact factor: 2.250
Authors: Anna L Gravier; Omar Shamieh; Carlos Eduardo Paiva; Pedro Emilio Perez-Cruz; Mary Ann Muckaden; Minjeong Park; Eduardo Bruera; David Hui Journal: Support Care Cancer Date: 2019-12-19 Impact factor: 3.603
Authors: Virginia Samuels; Tasha M Schoppee; Amelia Greenlee; Destiny Gordon; Stacey Jean; Valandrea Smith; Tyra Reed; Sheri Kittelson; Tammie Quest; Sean O'Mahony; Josh Hauser; Marvin O Delgado Guay; Michael W Rabow; Linda Emanuel; George Fitchett; George Handzo; Harvey Max Chochinov; Yingwei Yao; Diana J Wilkie Journal: Am J Hosp Palliat Care Date: 2021-02-09 Impact factor: 2.090
Authors: Imogen Ramsey; Belle H de Rooij; Floortje Mols; Nadia Corsini; Nicole J E Horevoorts; Marion Eckert; Lonneke V van de Poll-Franse Journal: J Cancer Surviv Date: 2019-09-06 Impact factor: 4.442
Authors: Femke Jansen; Ruud H Brakenhoff; Rob J Baatenburg de Jong; Johannes A Langendijk; C René Leemans; Robert P Takes; Chris H J Terhaard; Jan H Smit; Irma M Verdonck-de Leeuw Journal: BMC Med Res Methodol Date: 2022-01-22 Impact factor: 4.615